Assert-IQ vs Reveal LINQ Insertable Cardiac Monitor
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your cardiology practice or health system prioritizes the absolute longest-term continuous monitoring, up to six years, for a broad spectrum of suspected heart rhythm disorders. This system is ideal for comprehensive arrhythmia detection and proactive clinician alerts, ensuring extensive data collection and timely intervention.
View Assert-IQ →Choose Reveal LINQ if…
Choose Reveal LINQ II if minimizing false alerts, particularly for atrial fibrillation and pauses, is a critical concern for your patient population. Its AccuRhythm AI algorithms enhance diagnostic yield and reduce unnecessary interventions, while its MRI compatibility offers an important advantage for patients who may require future imaging.
View Reveal LINQ →When choosing between the Assert-IQ™ Insertable Cardiac Monitor (ICM) system from Abbott Medical and the Reveal LINQ II™ Insertable Cardiac Monitor from Medtronic, physicians should consider their primary needs for arrhythmia detection and data management. Assert-IQ™ excels in providing long-term, continuous monitoring for up to six years, coupled with advanced arrhythmia detection algorithms and proactive clinician alerts. Its secure, cloud-based data platform and remote monitoring capabilities are well-suited for large health systems and cardiology clinics prioritizing comprehensive, extended surveillance and direct clinician notification.
The key practical difference lies in their AI application and battery longevity. Reveal LINQ II™, with its AccuRhythm™ AI algorithms, focuses on enhancing diagnostic yield by significantly reducing false alerts, particularly for atrial fibrillation and pauses. This can streamline data review and potentially reduce clinician burden. While Assert-IQ™ offers a longer monitoring duration, Reveal LINQ II™ provides a nominal 4.5-year battery life and features remote programming capabilities, along with MRI compatibility. Physicians prioritizing highly accurate, AI-filtered data to minimize false positives and optimize diagnostic efficiency, especially in settings where reducing alert fatigue is critical, may find Reveal LINQ II™ more aligned with their needs. Conversely, those seeking the absolute longest monitoring duration and a robust system for proactive alerts across a broad patient base might lean towards Assert-IQ™.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | Reveal LINQ |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Subcutaneously implanted device with mobile app connectivity | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Assert-IQTool A (Assert-IQ) offers the 'myMerlin Mobile App' for automatic data transmission and symptom logging, supported by a dedicated 'SyncUP Remote Monitoring Support' team to assist patients with setup and connectivity. While Tool B (Reveal LINQ) also has a patient app, user reviews indicate potential issues with its reliability, such as the app randomly malfunctioning or not displaying recorded data to the user, suggesting a less consistent patient experience.
Clinical Value
Assert-IQBoth tools offer significant clinical value through AI-driven false alert reduction. However, Tool A (Assert-IQ) claims a higher reduction in false positives for AF and Pause episodes (98.7%) while maintaining high sensitivity (97.7% of true events). Additionally, Assert-IQ boasts a longer battery life of up to 6 years, compared to Reveal LINQ's 4.5 years, providing extended continuous monitoring.
Pricing & Value
TieBoth Assert-IQ and Reveal LINQ are advanced medical devices with non-transparent, enterprise-level pricing that requires direct contact with the respective vendors. Neither tool offers a free trial. Without specific pricing information or comparative cost-effectiveness studies, it is not possible to definitively determine a winner in this dimension.
Enterprise Readiness
TieBoth tools are developed by major, established medical device manufacturers (Abbott and Medtronic) and are designed for deployment in large health systems, hospitals, and cardiology clinics. Both are HIPAA compliant, and Tool B explicitly mentions having a Business Associate Agreement (BAA), which is implied by Tool A's HIPAA compliance. Both also offer remote programming capabilities for clinicians, indicating strong enterprise-level functionality.
Innovation
Assert-IQWhile both tools leverage AI for false alert reduction, Tool A (Assert-IQ) distinguishes itself by combining its advanced AI algorithms with the industry's longest-lasting Bluetoothu00ae ICM (up to 6 years) and 'IQ Insights' for holistic patient management. This broader integration of AI with extended monitoring capabilities and intelligent diagnostics provides a slightly more comprehensive innovative offering compared to Tool B's primary focus on its AccuRhythmu2122 AI for false alert reduction.
Support & Docs
TieBoth Abbott and Medtronic, as leading medical device companies, provide extensive support and documentation for their ICM systems. Tool A offers clinician and patient manuals, including specific guides for its mobile app, and dedicated remote monitoring support. Tool B also provides comprehensive product and technical support, patient services, and educational materials. Given the robust offerings from both, they are equally matched in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Reveal LINQ |
|---|---|---|
| Name | Assert-IQ | Reveal LINQ Insertable Cardiac Monitor |
| Company | Abbott Medical | Medtronic |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope. |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting) |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Reveal LINQ.